DDR2 and squamous cell lung carcinoma: DDR1 overexpression is associated with increased cell survival and invasion in hepatocellular carcinomas, pituitary adenoma and prostate cancer [17–19], whereas DDR2 is mutated in squamous cell lung cancers [20] and contributes to breast cancer metastasis [21].